Melanie Boxberg

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model.

Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model.

Journal: BMC medicine

Published: January 08, 2026

Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer.

Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancer.

Journal: Genome medicine

Published: August 08, 2025

PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression.

PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 10, 2025

Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data.

Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data.

Journal: IEEE transactions on medical imaging

Published: March 03, 2025

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer.

Journal: Molecular cancer

Published: October 09, 2024

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma.

Journal: NPJ precision oncology

Published: August 15, 2024

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Journal: Nature communications

Published: March 16, 2024

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.

Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas.

Journal: British journal of cancer

Published: February 09, 2024

Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.

Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.

Journal: British journal of cancer

Published: January 08, 2024

Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.

Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients.

Journal: Cancers

Published: May 30, 2023

Molecular subtyping of head and neck cancer - Clinical applicability and correlations with morphological characteristics.

Molecular subtyping of head and neck cancer - Clinical applicability and correlations with morphological characteristics.

Journal: Oral oncology

Published: May 17, 2023

Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report.

Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report.

Journal: World journal of gastroenterology

Published: May 13, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026